Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Cardiovascular Research|March 15, 2006
Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in miceHidenori Matsusaka, Tomomi Ide, Shouji Matsushima, et al.
Journal of Cardiovascular Pharmacology|October 13, 2006
Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarctionHidenori Matsusaka, Shintaro Kinugawa, Tomomi Ide, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 5, 2004
[Hepatic arterial infusion therapy for pancreatic cancer]Yasuhiko Miura, Michio Ueda, Osamu Kunihiro, et al.
Journal of Virology|May 1, 2009
Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8Toru Kubota, Mayumi Matsuoka, Tsung-Hsien Chang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alphaHajime Funakoshi, Toru Kubota, Yoji Machida, et al.
The Journal of Biological Chemistry|July 19, 2008
Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expressionToru Kubota, Mayumi Matsuoka, Tsung-Hsien Chang, et al.
Cardiovascular Research|May 26, 2005
Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathyNatsumi Kawamura, Toru Kubota, Shunichi Kawano, et al.
Immunity|August 19, 2007
The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8Prafullakumar Tailor, Tomohiko Tamura, Hee Jeong Kong, et al.
Pageof 14